Article
Safety assessment of recalled Haemophilus influenzae type b (Hib) conjugate vaccines--United States, 2007-2008.
Pharmacoepidemiology and drug safety - 1 Mar 2010
Huang Wan-Ting, Chang Soju, Miller Elaine R, Woo Emily Jane, Hoffmaster Alex R, Gee Jay E, Clark Thomas A, Iskander John K, Ball Robert, Broder Karen R
Abstract excerpt
PURPOSE: On 13 December 2007, Merck & Co., Inc. voluntarily recalled 1.2 million doses of Haemophilus influenzae type b (Hib) vaccines that had been distributed since April 2007 for concerns regarding potential Bacillus cereus contamination. Enhanced postrecall surveillance was conducted to detec...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
